Dr. Sharada Mailankody

Associate Professor

Reg.No:KRL20120001065KTK

Department of Medical Oncology

ACADEMIC QUALIFICATIONS

Degree Specialisation Institute Year of passing
DM Medical Oncology Cancer Institute (WIA), Adyar, Chennai August 2018
MD General Medicine JIPMER, Puducherry April 2015
MBBS None Government Medical College, Kozhikode September 2010

Experience

Institution / Organisation Designation Role Tenure
Department of Medical Oncology, Kasturba Medical College, 365体育投注 Associate Professor Teaching August 2021 till date
Department of Medical Oncology, Kasturba Medical College, 365体育投注 Assistant Professor Teaching July 2019 till July 2021
Tata Memorial Hospital, Mumbai Assistant Professor Teaching October 2018 till July 2019

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Interest

Competency-based medical education, communication in oncology, oncological emergencies

Area of Expertise

Breast and gynecological cancers, thoracic oncology, palliative and supportive care

Area of 365体育投注

Supportive care in cancer, gender issues in oncology, geriatric oncology, rare cancers, gynaecological and breast cancer, thoracic cancers, urological cancers.

Professional Affiliations & Contributions

Member of ISMPO, ESMO.

Reviewer for Indian Journal of Medical and Pediatric Oncology, Cancer 365体育投注 Statistics and Treatment, eCancermedicalscience, Cancer Medicine. ?

?

Additional qualifications:

?

1.???? ESMO accreditation for excellent knowledge in the field of expertise

2.???? Certificate course in palliative care under Indian Academy of Palliative Medicine, 2019 (Part A and B)?

3.? ? ?Revised Basic Medical Education Workshop (NMC recognized), 2021.

4.? ? ?Basic Course in Biomedical 365体育投注 (ICMR), 2021.

5.? ? ?Certificate Program in?Precision?Medicine and?Oncology?Genomics offered by the American College of Clinical Pharmacy (ACCP)

1.???? Mailankody S, Kumar VS, Khan SA, Banavali SD, Bajpai J. Resource-appropriate selection of osteosarcoma treatment protocols in low- and middle-income countries. Pediatr Blood Cancer. 2021 Dec 31:e29540. doi: 10.1002/pbc.29540. Epub ahead of print. PMID: 34971016.???

2.????? Mailankody S, Rao SR. "PENS" approach for breaking bad news-a short and sweet way! Support Care Cancer. 2021 Mar;29(3):1157-1159. ?

3.????? Mailankody S, Dhanushkodi M, Ganesan TS, Radhakrishnan V, Christopher V, Ganesharajah S, Sagar TG. Recurrent cervical cancer treated with palliative chemotherapy: real-world outcome. Ecancermedicalscience. 2020 Oct 13;14:1122. doi: 10.3332/ecancer.2020.1122.

4.????? Bajpai?J, Mailankody?S, Nair?R, et?al. Gender climate in Indian oncology: national survey report. ESMO Open 2020;5:e000671. doi:10.1136/ esmoopen-2020-000671

5.????? Mailankody, S., Bajpai, J., Godkhindi, V., Bedmutha, A. and Banavali, S. (2020), Widely disseminated metastatic Ewing sarcoma: Sustained, complete metabolic response to first-line oral metronomic chemotherapy. Pediatr Blood Cancer, 67: e28375.?https://doi.org/10.1002/pbc.28375

6.????? D Amalnath and S Mailankody. Cockayne syndrome with extensive intracranial calcification. Neurology 2015;84;e137.

7.????? Mailankody S, Dangeti GV, Soundravally R, Joseph NM, Mandal J, Dutta TK, Kadhiravan T. Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis. PLoS One. 2017 Jul 12;12(7):e0181262. doi: 10.1371/journal.pone.0181262. PMID: 28704492; PMCID: PMC5507543.

8.????? Dangeti GV, Mailankody S, Neeradi C, Mandal J, Soundravally R, Joseph NM, Kamalanathan S, Swaminathan RP, Kadhiravan T. Vitamin D deficiency in patients with tuberculous meningitis and its relationship with treatment outcome. Int J Tuberc Lung Dis. 2018 Jan 1;22(1):93-99.?

9.????? S Deepanjali, R R. Naik, S Mailankody, S Kalaimani, and T Kadhiravan. Dengue Virus Infection Triggering Thrombotic Thrombocytopenic Purpura in Pregnancy. Am J Trop Med Hyg. 2015; 93(5): 1028–1030

10.? ? ? ?Mailankody S, Radhakrishnan V, Raja A, Ganesan TS, Dhanushkodi M, Sagar TG. Outcomes with chemotherapy in carcinoma penis: Experience from a tertiary cancer center. Indian J Cancer [Epub ahead of print] [cited?2022 Aug 28]. Available from:?https://www.indianjcancer.com/preprintarticle.asp?id=353185

11.? ?Bajpai J, Mailankody S, Garrido P, Peters S. Perception and Improvisation of Gender Climate in Oncology and Role of 365体育投注 and National Societies; Indian J Med Paediatr Oncol 2022; 43(01): 004-007. DOI: 10.1055/s-0042-1742656

12.????? Mailankody S, Bajpai J. Intelligent adaptation to the changing surroundings amidst the COVID-19 pandemic for sarcomas and melanomas. Cancer Res Stat Treat 2020;3, Suppl S1:110-4

13.? ? ? Mailankody S, Bajpai J. Gender equity in oncology: Past, present, and future!. Indian J Med Paediatr Oncol 2020;41:163-5

14.? ? ?Mailankody S, Bajpai J, Gupta S. "Petite"?p?value: A 365体育投注ers' Dream! Readers, Beware of the?Pit ….?Indian J Crit Care Med. 2020;24(Suppl 3):S140-S141. doi:10.5005/jp-journals-10071-23399

15.? ? ?Mailankody S. Doctoring in the time of COVID-19 – Lessons learned. Cancer Res Stat Treat 2020;3:427-8

16.? ? Mailankody S. Palliative care in oncology. Indian J Med Paediatr Oncol 2020;41:215-7

17.? ? ?Mailankody S, Bajpai J. How I Treat sarcomas during COVID-19 pandemic: Caught between the devil and the deep sea!. Indian J Med Paediatr Oncol 2020;41:299-302

18.? ? ?Mailankody S. Modified dose dexamethasone premedication for paclitaxel use. Cancer Res Stat Treat 2018;1:116-7

19.? Menon N, Mailankody S. Immunotherapy protocols in lung cancer. Cancer Res Stat Treat 2018;1:139-62

20.? Mailankody S, Ganesan P, Joshi A, Ganesan TS, Radhakrishnan V, Dhanushkodi M, Mehra N, Kalaiyarasi JP, Kannan K, Sagar TG. Outcomes of Oral Metronomic Therapy in Patients with Lymphomas. Indian J Hematol Blood Transfus. 2019 Jan;35(1):50-56. doi: 10.1007/s12288-018-0995-0

21. M Sharada, M Vadivelan. Nutrition in critically ill patients. Journal of Indian Academy of Clinical Medicine, JIACM 2014; 15(3-4): 205-9